Early mNGS Testing Cuts Diagnosis Time in CNS Infections
BOSTON, January 22, 2026 — Delve Bio announced new clinical evidence demonstrating that earlier use of metagenomic next-generation sequencing...
Infectious Diseases
Advertisement
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Advertisement
